Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 144 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission

NCT00093470

Conditions
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monocytic Leukemia, +31 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Kaiser Permanente-San Diego Mission San Diego, California, United States
View all 341 locations
View Trial Details
Completed

A Study to Evaluate Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) in Patients With Polycythemia Vera

NCT05143957

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +7 more
Locations
  • O'Neal Comprehensive Cancer Center University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
View all 13 locations
View Trial Details
Completed

LOW-PV Continuation

NCT06752941

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Fondazione IRCCS Policlinico San Matteo, Divisione Ematologia Pavia, Lombardy, Italy
  • Ospedale Borgo Roma, Divisione Ematologia Verona, Veneto, Italy
  • ASST Papa Giovanni XXIII, SC Ematologia Bergamo, Italy
  • Policlinico S. Orsola - Malpighi, UO Ematologia Bologna, Italy
View all 13 locations
View Trial Details
Completed

Ruxolitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis.

NCT03427866

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • The Ohio State University Wexner Medical Center Columbus, Ohio, United States
View Trial Details

Related conditions